Nature Medicine
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial
Randomised trial in 284 peopleType 2 diabetes
Papers by Shuang Yan
2 results
- World Journal of Pediatrics
Impact of growth markers and patterns of growth on children's cardiometabolic health: a life course perspective
Study in peoplePopulations